Inventors:
Ray W. Exley - Beverly Hills CA, US
International Classification:
A61K 31/52, C07D 473/18, C07D 473/34, C07F 9/6561, A61K 31/522, A61P 37/02, A61P 25/00, A61P 31/22, A61P 21/02, A61P 21/00, A61P 29/00, A61P 13/12, A61K 31/675
US Classification:
514 81, 544276, 544277, 544244, 51426338
Abstract:
Anti-herpetic material such as 2-amino purine derivatives to prevent or treat autoimmune disease or a disease originating from an abnormal functioning of the sympathetic chain in a human subject. The disease is often of a tissue or organ associated with decreased blood flow to the tissue or organ (correlated with hypertonicity of the vessels feeding the tissue or organ). The treatment reduces inflammation, scarring, destruction, and pain in the tissue or organ affected and returns the tissue or organ to nearly normal functioning, while showing none of the side effects of previous treatments. Prolonged use of the anti-herpetic compounds reduces prodrome, vesicle formation and viral shedding. The anti-herpetic compounds may be administered alone or in combination with a compound that reduces the rate of renal excretion of the anti-herpetic compound. The anti-herpetic compounds are particularly useful when administered at a level equivalent in activity to 250 mg/kg famciclovir per day.